Navigation Links
Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes
Date:10/26/2011

EMERYVILLE, Calif., Oct. 26, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that enrollment has started to the Phase 3 pivotal clinical trial evaluating the safety and efficacy of two doses of Menerba™ (MF101) among a cohort of postmenopausal women for the treatment of menopausal hot flashes.

The Phase 3, multicenter, double-blind, placebo-controlled, randomized clinical trial evaluating Menerba is currently open for enrollment. A total of 50 clinical sites in the U.S. will enroll 1,200 postmenopausal women between the ages of 40 and 65 years. Participants will be randomized to Menerba 5g/day, Menerba 10g/day or placebo and treated for 12 weeks. The primary aims of the study are to determine the safety and efficacy of two doses of Menerba compared to placebo after 12 weeks of treatment.  Efficacy will be measured by the reduction of moderate to severe hot flushes from baseline to 12 weeks of treatment. Dr. Wulf Utian, Executive Director Emeritus and Honorary Founding President of the North America Menopause Society and Professor Emeritus at Case Western Reserve University is serving as the Principal Investigator for the study.

"We have had a very busy and productive year preparing for today's important launch of the late stage clinical trial in the field of women's health. As predicted from our vast toxicology data and the mechanism of action, we showed that higher doses of Menerba were very safe and demonstrated a level of efficacy similar to hormone therapy. Today we are proceeding with our first pivotal Phase 3 trial of Menerba with great optimism and enthusiasm. We are elated to be one step closer to providing a truly novel agent for the treatment of menopausal hot flashes to the 40 million women in need of
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society
2. Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaqs Bid Price Rule
3. CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
4. Bionovo Announces Second Quarter 2011 Highlights and Financial Results
5. Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
6. Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011
7. Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes
8. Bionovo Announces 2010 Highlights and Year-End Financial Results
9. Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011
10. Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
11. Bionovo Announces 2011 Plan of Action on MF101 (Menerba™)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
(Date:8/31/2015)... , Aug. 31, 2015  DICOM Grid,  ... today that it was recognized as a semifinalist ... software.  The awards are sponsored by ... related professionals in the medical imaging industry.  Since ... radiology professionals to acknowledge the contributions of their ...
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
Breaking Medicine Technology:Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2
... Tenn. , May 20 /PRNewswire-FirstCall / -- Cumberland Pharmaceuticals Inc. ... acute care and gastroenterology markets, today announced that Chief Commercial Officer ... Global Life Sciences Conference in New York at 11:30 ... , , , ...
... , May 20 LightLab Imaging, Inc. announced today that ... leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University ... available to hospitals in the United States – Optical Coherence ... Dr. Costa ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 3
(Date:8/31/2015)... ... , ... According to an article published August 3rd on Healio, ... underwent bariatric surgery “felt significantly better two years after surgery.” The article goes on ... study felt that their “mental health had been normalized” at the point when the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Dad Phil, son Scott, ... on Aug. 26, generously hosted by the Collinsville Chamber of Commerce, but the ... Call Center and website since Aug. 17. , The Greens have operated Green ...
(Date:8/31/2015)... Knoxville, TN (PRWEB) , ... August 31, 2015 ... ... of urgent care and accessible primary care, is enhancing its existing presence in ... Pike in Knoxville. The location is the company’s second in Knoxville, sixteenth in ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a leader ... competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the company’s ... Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking place ...
(Date:8/31/2015)... IL (PRWEB) , ... August 31, 2015 , ... In ... studies, Etymotic Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 ... sound amplifiers as a way of coping with a variety of home healthcare challenges, ...
Breaking Medicine News(10 mins):Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:Ribbon Cutting Launches AdvantaClean of Madison County 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3
... YORK (Aug. 21, 2007) -- A breakthrough new ... and adults with a common type of congenital ... to oxygenate blood through the lungs. , The ... the first-ever catheter-based pulmonary valve replacement, is currently ...
... researchers say , WEDNESDAY, Aug. 22 (HealthDay News) -- ... humans with obsessive-compulsive disorder (OCD), scientists report. , The ... cells from producing a protein called SAPAP3, according to ... an important role in the transmission of signals between ...
... a dark side, but also a new way it ... -- It looks like HDL, the "good" cholesterol that ... side. , New research suggests that some people,s HDL ... that certain proteins in HDL can exacerbate vessel damage, ...
... scientists reported findings today demonstrating the presence of Marburg ... of African fruit bat (Rousettus aegyptiacus). , ... study is the first in which RT-PCR and serological ... bat species. The natural reservoir for Marburg virus has ...
... of secondary procedures , , TUESDAY, Aug. 21 (HealthDay News) ... peritonitis may not automatically need to undergo more operations ... In the United States, most surgeons choose to wait ... surgery, said Dr. David Flum, a gastrointestinal surgeon at ...
... highly effective in preventing the behavioral and academic problems ... a five-year study led by researchers at Lehigh Universitys ... and funded by the National Institute of Mental Health ... children aged 3 to 5 who have shown significant ...
Cached Medicine News:Health News:NYC-area 1st: Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement 2Health News:When 'Good' Cholesterol Goes Bad 2Health News:Scientists detect presence of marburg virus in african fruit bats 2Health News:One Surgery Often Enough for Peritonitis 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 2Health News:Nonmedicinal treatment touted for preschoolers with ADHD 3
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... X-Drape combines full 0.25 mm pb ... sterile drape material that can be ... between the clinician and the source ... clinician must be in very close ...
... The first mobile clinical assistant ... A convergence of technologies in the ... you normally do during your,shift such ... and take pictures using one single ...
Patent Pending lateral flow assay platform that contributes to increased sensitivty...
Medicine Products: